African Journal of
Pharmacy and Pharmacology

  • Abbreviation: Afr. J. Pharm. Pharmacol.
  • Language: English
  • ISSN: 1996-0816
  • DOI: 10.5897/AJPP
  • Start Year: 2007
  • Published Articles: 2288

Full Length Research Paper

The effects of tongdujianbu particle treatment on matrix metallopeptidase 9 (MMP-9), tissue inhibitor of metalloproteinase (TIMP)-1, and transformation growth factor (TGF)-β1 expression in a rat model of spinal core injury

Yi Luo1*, Zhansheng Deng1, Shu Huang2 and Mei Wei3
1Department of Spine surgery, Xiang Ya Hospital, Central South University, 87 Xiangya Road, Changsha, Hunan 410008 China. 2Renmin Hospital, 61 Jiefang West Road, Changsha, Hunan 410005 China. 3Yi Fang Pharmaceutical Company, Qifeng Kaifaqu, Lishui, Nanhai District, Foshan, Guangdong 528244 China.
Email: [email protected], [email protected]

  •  Accepted: 20 February 2012
  •  Published: 29 April 2012

Abstract

This work investigated the effect of tongdujianbu particle (TP) on the expression patterns ofmatrix metallopeptidase 9 (MMP-9), tissue inhibitor of metalloproteinase (TIMP)-1 and transformation growth factor (TGF)-β1 and the behavioural changes in a rat model of spinal cord injured (SCI). A total of 105 adult Sprague-Dawley rats were used for the spinal cord injury as well as different groups of TP treatments. The expression level of MMP-9, TIMP-1, TGF-β1 and Nissl bodies’ distribution in the injured spinal cord were examined. Basso-Beattie-Bresnahan (BBB) behavioural score was used to evaluate the recovery of the motor ability. The results suggested that the TP improved the recovery of the behavioural functionality post-SCI. The TP treatment could inhibit the expression of MMP-9 and enhance the expression of TIMP-1, and alter the MMP-9/TIMP-1 ratio whilst maintaining the MMP-9 and TIMP-1 equilibrium. The TP treatment could enhance the expression of TIMP-1 by stimulation of TGF-β1 expression. We concluded that the TP treatment provides a potential approach in integrative medicine for improved SCI recovery.

 

Key words: Tongdujianbu particle, spinal cord injury, matrix metallopeptidase 9 (MMP-9), tissue inhibitor of metalloproteinase (TIMP)-1, transformation growth factor (TGF)-β1 , blood spine barrier, BBB behavioural function score, immunohistology.